Internal Medicine, Hematology & Oncology · Salem, OR
NPI
1518922111
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
875 Oak St SE, Suite 4030
Salem, OR, 97301
Phone (503) 561-6444
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
134,026 services
Medicare patients, 2024
631
Average age 73
Drug cost, 2024
$6.9M
2,589 prescriptions
Company payments, 2025
$668
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John M Strother was code J1439 (injection, ferric carboxymaltose, 1 mg), 19,500 times for 21 patients. In total John M Strother billed 134,026 services in 170 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 19,500 | 21 | $0.80 | $16K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 13,650 | 43 | $0.11 | $1,494 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,000 | 17 | $44.59 | $312K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,549 | 82 | $0.09 | $224 |
| J0897 Injection, denosumab, 1 mg | Office | 2,100 | 15 | $20.80 | $44K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,340 | 51 | $0.67 | $891 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,184 | 37 | $0.07 | $85.01 |
| 85025 Blood Count | Office | 949 | 335 | $7.54 | $7,160 |
| 80053 Clinical Chemistry | Office | 927 | 320 | $10.27 | $9,522 |
| 36415 Venipuncture Blood Collection | Office | 572 | 270 | $8.63 | $4,939 |
| 99214 Office E&M - Established | Office | 440 | 215 | $90.83 | $40K |
| 96413 Chemotherapy Administration | Office | 398 | 110 | $105.55 | $42K |
| J9045 Injection, carboplatin, 50 mg | Office | 384 | 18 | $2.81 | $1,079 |
| 96367 Intravenous Infusion, Hydration | Office | 257 | 80 | $23.05 | $5,925 |
| 96375 Injection Administration | Office | 240 | 74 | $12.18 | $2,924 |
By year: 2022 $1.6M for 96,910 services; 2023 $1.4M for 98,324 services; 2024 $2.5M for 134,026 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 949 | 335 | $7.54 | $7,160 |
| 80053 Clinical Chemistry | 927 | 320 | $10.27 | $9,522 |
| 36415 Venipuncture Blood Collection | 572 | 270 | $8.63 | $4,939 |
| 83735 Clinical Chemistry | 103 | 43 | $6.57 | $677 |
| 84443 Clinical Chemistry | 63 | 40 | $16.46 | $1,037 |
| 83521 Immunoassay | 57 | 34 | $16.92 | $964 |
| 82728 Clinical Chemistry | 56 | 45 | $13.19 | $739 |
| 83615 Clinical Chemistry | 45 | 41 | $5.92 | $266 |
| 83550 Clinical Chemistry | 31 | 31 | $8.37 | $260 |
| 83540 Clinical Chemistry | 31 | 31 | $6.19 | $192 |
Medicare prescription drug claims, 2024
In 2024, the drug John M Strother prescribed most often to Medicare patients was Anastrozole, with 282 prescriptions and refills. In total John M Strother wrote 2,589 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 282 | 809 | 84 | $6,124 |
| Hydroxyurea Generic | 108 | 236 | 24 | $2,811 |
| Gabapentin Generic | 108 | 164 | 20 | $1,841 |
| Tamoxifen Citrate Generic | 103 | 231 | 27 | $2,592 |
| Prochlorperazine Maleate Generic | 96 | 96 | 54 | $1,294 |
| Acyclovir Generic | 77 | 137 | 22 | $997 |
| Eliquis Apixaban | 70 | 114 | 19 | $65K |
| Abiraterone Acetate Generic | 69 | 70 | Under 11 | $59K |
| Levothyroxine Sodium Generic | 65 | 102 | 16 | $544 |
| Oxycodone Hcl Generic | 63 | 63 | 25 | $1,354 |
| Olanzapine Generic | 62 | 68 | 17 | $559 |
| Prednisone Generic | 62 | 116 | 27 | $339 |
| Letrozole Generic | 57 | 130 | 22 | $1,439 |
| Potassium Chloride Generic | 52 | 83 | 12 | $1,822 |
| Dexamethasone Generic | 52 | 56 | 25 | $899 |
Brand drugs: - claims; generic drugs: 2,050 claims; opioid claims: 220.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John M Strother $668 ($668 in general payments such as food, travel and fees) from 19 companies. The largest payer was BeOne Medicines USA, Inc. with $202.
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. ONC | 5 | $202 |
| Pfizer Inc. PFE | 5 | $107 |
| GlaxoSmithKline, LLC. GSK | 3 | $73.98 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $44.49 |
| Merck Sharp & Dohme LLC MRK | 2 | $38.53 |
| Abbvie Inc. ABBV | 1 | $28.25 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $26.57 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $24.58 |
| Genzyme Corporation SNY | 1 | $20.91 |
| SpringWorks Therapeutics, Inc. | 1 | $20.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.